Shunchao Yan

419 total citations
22 papers, 335 citations indexed

About

Shunchao Yan is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Shunchao Yan has authored 22 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 10 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Shunchao Yan's work include Estrogen and related hormone effects (11 papers), HER2/EGFR in Cancer Research (7 papers) and BRCA gene mutations in cancer (3 papers). Shunchao Yan is often cited by papers focused on Estrogen and related hormone effects (11 papers), HER2/EGFR in Cancer Research (7 papers) and BRCA gene mutations in cancer (3 papers). Shunchao Yan collaborates with scholars based in China, United States and South Africa. Shunchao Yan's co-authors include Xin Jiao, Huawei Zou, Kai Li, Yunpeng Liu, Yuee Teng, Lingyun Zhang, Ling Xu, Xiujuan Qu, Zhitu Zhu and Sung Hoon Kim and has published in prestigious journals such as SHILAP Revista de lepidopterología, Endocrinology and eLife.

In The Last Decade

Shunchao Yan

20 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shunchao Yan China 9 158 151 119 97 45 22 335
Tenghua Yu China 10 213 1.3× 157 1.0× 139 1.2× 127 1.3× 33 0.7× 30 380
Ewoud N. Speksnijder Netherlands 11 288 1.8× 223 1.5× 47 0.4× 125 1.3× 36 0.8× 15 470
Fergus Keane United States 10 85 0.5× 113 0.7× 33 0.3× 61 0.6× 32 0.7× 40 271
Marina Riggio Argentina 8 206 1.3× 97 0.6× 60 0.5× 63 0.6× 44 1.0× 8 309
Lin‐wen Wu China 12 225 1.4× 88 0.6× 43 0.4× 82 0.8× 69 1.5× 18 381
Everardo Macias United States 9 155 1.0× 71 0.5× 29 0.2× 150 1.5× 74 1.6× 15 331
Valentina Vircillo Italy 6 169 1.1× 130 0.9× 68 0.6× 139 1.4× 54 1.2× 6 302
Jeannette Huaman United States 6 155 1.0× 73 0.5× 26 0.2× 111 1.1× 49 1.1× 7 310
Nicole Carlson United States 6 186 1.2× 175 1.2× 144 1.2× 83 0.9× 45 1.0× 6 352
Emilia Rippa Italy 14 215 1.4× 47 0.3× 43 0.4× 88 0.9× 74 1.6× 27 436

Countries citing papers authored by Shunchao Yan

Since Specialization
Citations

This map shows the geographic impact of Shunchao Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shunchao Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shunchao Yan more than expected).

Fields of papers citing papers by Shunchao Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shunchao Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shunchao Yan. The network helps show where Shunchao Yan may publish in the future.

Co-authorship network of co-authors of Shunchao Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Shunchao Yan. A scholar is included among the top collaborators of Shunchao Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shunchao Yan. Shunchao Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yan, Shunchao, et al.. (2025). Targeting the initiator to activate both ferroptosis and cuproptosis for breast cancer treatment: progress and possibility for clinical application. Frontiers in Pharmacology. 15. 1493188–1493188. 3 indexed citations
2.
Yan, Shunchao, et al.. (2025). Targeting hormone-related signals to reprogram the antitumor immune response in breast cancer: Research progress and application prospects. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1880(5). 189390–189390.
4.
Zhang, Duo, et al.. (2024). Current progress and prospects for G protein-coupled estrogen receptor in triple-negative breast cancer. Frontiers in Cell and Developmental Biology. 12. 1338448–1338448. 6 indexed citations
5.
Zhang, Jiao, et al.. (2024). Comparative analysis of human and mouse transcriptomes during skin wound healing. Frontiers in Cell and Developmental Biology. 12. 1486493–1486493. 2 indexed citations
6.
Wang, Maochun, et al.. (2024). Identification of the miRNA–mRNA regulatory network in a mouse model of early fracture. Frontiers in Genetics. 15. 1408404–1408404. 2 indexed citations
7.
Yan, Shunchao, et al.. (2024). Targeting the crosstalk between estrogen receptors and membrane growth factor receptors in breast cancer treatment: Advances and opportunities. Biomedicine & Pharmacotherapy. 175. 116615–116615. 6 indexed citations
9.
Yan, Shunchao, et al.. (2023). Divergent features of ERβ isoforms in triple negative breast cancer: progress and implications for further research. Frontiers in Cell and Developmental Biology. 11. 1240386–1240386. 6 indexed citations
10.
Zhang, Duo, Jinpeng Wang, Hong Chen, & Shunchao Yan. (2022). Cytoplasmic G Protein-Coupled Estrogen Receptor 1 as a Prognostic Indicator of Breast Cancer: A Meta-Analysis. Technology in Cancer Research & Treatment. 21. 2213873552–2213873552. 6 indexed citations
11.
Yan, Shunchao, Parama Dey, Yvonne Ziegler, et al.. (2020). Contrasting activities of estrogen receptor beta isoforms in triple negative breast cancer. Breast Cancer Research and Treatment. 185(2). 281–292. 32 indexed citations
12.
13.
Yan, Shunchao, et al.. (2015). The impact of IGF-1R expression on the outcomes of patients with breast cancer: a meta-analysis. OncoTargets and Therapy. 8. 279–279. 19 indexed citations
14.
Yan, Shunchao, Xin Jiao, Huawei Zou, & Kai Li. (2015). Prognostic significance of c-Met in breast cancer: a meta-analysis of 6010 cases. Diagnostic Pathology. 10(1). 62–62. 65 indexed citations
16.
Yan, Shunchao, Xiujuan Qu, Ling Xu, et al.. (2014). Bufalin enhances TRAIL-induced apoptosis by redistributing death receptors in lipid rafts in breast cancer cells. Anti-Cancer Drugs. 25(6). 683–689. 33 indexed citations
17.
Yan, Shunchao, Xiujuan Qu, Zhitu Zhu, et al.. (2012). Down-regulation of Cbl-b by bufalin results in up-regulation of DR4/DR5 and sensitization of TRAIL-induced apoptosis in breast cancer cells. Journal of Cancer Research and Clinical Oncology. 138(8). 1279–1289. 53 indexed citations
18.
Jiao, Xin, Bo Jin, Xiujuan Qu, et al.. (2011). [Expressions of c-Cbl, Cbl-b and EGFR and its role of prognosis in NSCLC].. SHILAP Revista de lepidopterología. 14(6). 512–7.
19.
Yan, Shunchao, Yunpeng Liu, Lingyun Zhang, et al.. (2010). Ubiquitin ligase c-Cbl is involved in tamoxifen-induced apoptosis of MCF-7 cells by downregulating the survival signals. Acta Oncologica. 50(5). 693–699. 8 indexed citations
20.
Buzdar, Aman U., Daniel F. Hayes, Shunchao Yan, et al.. (2002). Phase III Randomized Trial of Droloxifene and Tamoxifen As First-Line Endocrine Treatment of ER/PgR-Positive Advanced Breast Cancer. Breast Cancer Research and Treatment. 73(2). 161–175. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026